AptaBio Therapeutics Inc (293780.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7293780003
AptaBio Therapeutics Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.36 bn KRW | 3.70 bn KRW |
| Gross profit | 286.62 m KRW | 1.33 bn KRW |
| Operating income | -18.85 bn KRW | -15.54 bn KRW |
| EBIT | -24.40 bn KRW | -13.22 bn KRW |
| Net income | -29.38 bn KRW | -16.35 bn KRW |
| Diluted EPS – continuing operations | -1,092.87 KRW | -581.85 KRW |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AptaBio Therapeutics Inc
AptaBio Therapeutics Inc., a biopharmaceutical company, develops platform based drugs for intractable diseases. Its platforms include Oxidative stress modulation platform for developing therapeutic agents for diabetes complications, vascular diseases, neurodegenerative diseases, and intractable cancers by controlling oxidative stress; Cancer-associated fibroblast control platform for developing new anticancer drugs for intractable cancer; and Aptamer-drug conjugate platform for developing intractable anticancer drugs with high unmet medical needs. The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX reagents for transfecting DNA or RNA into eukaryotic cells. The company was founded in 2009 and is based in Yongin-si, South Korea.
More stocks
- Ace Technologies Corp (088800.KQ)
- Chilean Cobalt Corp. (COBA)
- Hyosung Itx (094280.KS)
- Bank of San Francisco (BSFO)
- COSMO ROBOTICS CO., Ltd. (439960.KQ)
- Jason Co., Ltd. (4570.TWO)
- Lang Inc (6165.TW)
- Quaser Machine Tools (4563.TWO)
- FLITTO Inc (300080.KQ)
- Mitake Information (8284.TWO)
- Samsung Pharm (001360.KS)
- Haitai Confectionery and Foods Co Ltd (101530.KS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.